Echo IQ uses proprietary artificial intelligence to help identify patients at risk of structural heart disease.
Echo IQ has developed a cloud-based decision-support software, EchoSolv™, powered by Artificial Intelligence and Machine Learning, which aims to provide physicians with a reliable tool to identify patients at-risk of structural heart disease who may benefit from further referral. EchoSolv™ aims to improve the current standard clinical workflow associated with diagnosis and treatment.
Reference: https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds)